Serum C-reactive Protein (CRP) Level in Tuberculous Patients

N Naher1, L Helaly, Z H Sarker

  • 1Dr Nazmun Naher, Medical Officer, Institute of Public Health, Mohakhali, Dhaka, Bangladesh.

Insights

C-reactive protein (CRP) is a valuable tool for diagnosing and monitoring tuberculosis in children. Elevated CRP levels in tuberculous patients normalized after four weeks of treatment, indicating its prognostic utility.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Biochemistry

Background:

  • Tuberculosis (TB) diagnosis and prognosis in children require reliable biomarkers.
  • C-reactive protein (CRP) is an acute-phase reactant with potential diagnostic and prognostic value.

Purpose of the Study:

  • To evaluate the role of C-reactive protein (CRP) levels as a diagnostic and prognostic indicator in pediatric tuberculosis patients.

Main Methods:

  • A prospective case-control study involving 60 children (30 with TB, 30 healthy controls).
  • Serum CRP levels were measured in tuberculosis patients and compared to healthy children.
  • CRP levels were monitored during a four-week treatment period.

Main Results:

  • CRP was elevated (>6 mg/L) in 83.3% of pediatric tuberculosis cases.
  • A significant difference (p<0.001) in serum CRP levels was observed between TB patients and healthy children.
  • CRP levels normalized in patients after four weeks of anti-tuberculosis treatment.

Conclusions:

  • Serum C-reactive protein (CRP) is a useful biomarker for diagnosing tuberculosis in children.
  • CRP levels can serve as a prognostic indicator, reflecting treatment response in pediatric TB patients.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
699
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.4K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
864
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.4K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K